about
Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations.Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory diseaseProstaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease.Bacterial metabolites of diet-derived lignans and isoflavones inversely associate with asthma and wheezing.Addition of mycophenolate mofetil to tacrolimus is associated with decreases in food-specific IgE levels in a pediatric patient with liver transplantation-associated food allergy.Vitamin D Supplementation and the Risk of Colds in Patients with Asthma.Mastocytosis: update on pharmacotherapy and future directions.Update on reslizumab for eosinophilic asthma.Interleukin-5 Antagonists Usher in a New Generation of Asthma Therapy.Insulin resistance modifies the association between obesity and current asthma in adults.Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age.Biological therapies for eosinophilic asthma.A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory diseaseManagement of severe asthma: a European Respiratory Society/American Thoracic Society guidelineAdherence to adding inhaled corticosteroids to rescue therapy in a pragmatic trial with adults with asthma: A pilot study
P50
Q30276073-F428E95E-F643-4A98-BEE5-6E7A0354CBB8Q33598927-CB52AC9F-F76F-418F-84D4-C9044C7A8046Q33693274-B4B81334-6BC8-4D8C-9C22-523EC0BB8131Q34892954-CBA6A296-9433-438A-B823-56564FBE8896Q35124746-7F9A6223-EBF9-4AFB-8A34-73555180EB1CQ36778607-B8C3D9F5-BFC2-455A-A252-0A9EF6FE063CQ38138597-391FF4F4-B4CF-4694-8212-62C0AD9C37FBQ38587334-B1797239-A51A-438D-B77C-DDA3BB35A798Q38994743-15E68E8C-2EE8-4683-9CED-42DF5F1429D9Q40786711-E27A8211-32B6-40CF-ADA5-AC85BA09271FQ45066429-11852B1F-8BFC-4E30-A305-1E05F832241AQ64881193-DDC863C8-4777-43B5-B584-42A5A4DFD56AQ89064053-E1FF8ED3-2DA9-4871-8397-C2D0B11B73ECQ90316980-9D8C371A-BC01-487C-AD70-21882EA85218Q92555749-7E2B6A2F-2DC6-4498-91C8-A1ECDEE7153A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Juan Carlos Cardet
@ast
Juan Carlos Cardet
@en
Juan Carlos Cardet
@es
Juan Carlos Cardet
@nl
type
label
Juan Carlos Cardet
@ast
Juan Carlos Cardet
@en
Juan Carlos Cardet
@es
Juan Carlos Cardet
@nl
prefLabel
Juan Carlos Cardet
@ast
Juan Carlos Cardet
@en
Juan Carlos Cardet
@es
Juan Carlos Cardet
@nl
P106
P21
P31
P496
0000-0002-9731-4828